CHOP Researchers Redefine the Mechanisms of Dravet Syndrome
Published on
Recovery of normal signaling of a key brain cell may be a critical therapeutic target to reduce seizures and cognitive impairment.
Published on
Recovery of normal signaling of a key brain cell may be a critical therapeutic target to reduce seizures and cognitive impairment.
Published on
Measuring days children are minimally impacted by seizures could help researchers determine effectiveness of precision medicine clinical trials.
Published on
CHOP is the only center to capture standardized clinical data from ongoing patient care.
Published on
A dozen patients have clinical features linked to the genetic variants, and preclinical models reveal more about how they affect normal function.
Published on
When applying new terminology to existing data through computational methods, researchers increased the number of descriptive terms five-fold, improving diagnostic capabilities.
Published on
We saw great clinical and research growth in our first year in operation, despite the challenges of the COVID-19 pandemic.
Published on
In an effort to expand access to continuous EEG (CEEG) monitoring, CHOP recently initiated a pilot program of remote CEEG monitoring for at-risk neonates at two regional affiliated hospitals that provide neonatology services.
Published on
By standardizing how clinical information is analyzed, researchers found 11 causative genes associated with specific symptoms.
Published on
Assessing clinical data across the lifespan identified the impact of genetic epilepsies on affected children’s lives.
Published on
Findings demonstrate that telemedicine will likely have an important role in clinical care that lasts far beyond the current pandemic that facilitated its necessity.